| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |